yahoo_financeOriginal article
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
Phase 2positivePositive
AI Analysis
Summary
Quince Therapeutics announced positive Phase 2 study results showing clinically meaningful improvements in functional, hemodynamic, and biomarker measures for a treatment in PAH and PH-ILD patients.
Clinical Trial Data
Phase
2
Primary Endpoint
Met
Outcome Details
Clinically meaningful improvements across functional, hemodynamic and biomarker measures
Importance:7/10
Sentiment:
0.75
Phase 2 dataPAHPH-ILDclinical trialpositive results
Related Companies
Read the original article
Published by yahoo_finance on May 18, 2026 2:21 PM